A low-cost, drug-free way to reduce pain with mild electrical pulses through the skin. Pain falls while the current runs and briefly after, and less painkilling medication is needed after surgery. Gains in longer-lasting pain are smaller and depend on a strong but comfortable current, readjusted as the skin adapts. The downside is small. (Full Review)

Protocol

Conventional high-frequency protocol, the default in most clinics

80–120 pulses per second, 30–60 minutes

Pulse width 50–200 microseconds; strong but comfortable tingling, no twitch.

Acupuncture-like low-frequency protocol, the main alternative

2–10 pulses per second, 20–30 minutes

Pulse width 100–400 microseconds; rhythmic, non-painful twitch.

Modulated-frequency protocol, used in the largest positive trial

2–125 pulses per second, 2 hours daily

Highest tolerable intensity, during activity.

Time to effect

Pain relief within a session

Within minutes

Maximal by 20 to 30 minutes.

Carry-over after the current stops

30 minutes to several hours

Longer at low frequency; shortens with tolerance.

Cumulative benefit

2 to 4 weeks

Where it occurs, over ten or more sessions.

Benefits

High: Reduced pain during and just after stimulation; less analgesic medication after surgery

Medium: Movement-evoked pain and fatigue in fibromyalgia; pain and function in knee osteoarthritis; less pain sensitization and hyperalgesia; less post-stroke spasticity

Low: Chronic low back, neuropathic, and menstrual pain; lower pro-inflammatory signalling proteins

Speculative: Cardiac autonomic balance; physical activity and independence with age; less analgesic burden

Contraindications

Cardiac implantable electronic devices, electrodes both sides or across the chest

Front of the neck and the carotid sinus

Across the head or over the eyes

Pregnancy: abdominal, pelvic, lumbosacral outside labour, especially first trimester

Broken, infected, or cancer-affected skin; deep vein thrombosis at the site

Key Interactions

Opioid analgesics (morphine, oxycodone)

Opioid receptor antagonists (naltrexone)

Caffeine, adenosine receptor antagonists

Over-the-counter analgesics (ibuprofen)

Topical products under electrodes (capsaicin)

Anti-inflammatory supplements (curcumin)

Sedatives and alcohol impairing sensation

Other neuromodulation (electroacupuncture)

Uncontrolled epilepsy (seizure within 12 months)

Complete sensory loss (failed monofilament test)

Infusion pumps, cochlear and other implants

Cannot operate device or report sensation (moderate to severe dementia)

Risk & Side Effects

High: Skin irritation and dermatitis under the electrodes; intolerable stimulation limiting the dose

Medium: Analgesic tolerance with fixed parameters; cardiac device interference; superficial burns

Low: Masking of undiagnosed disease; electrode adhesive allergy; dizziness, nausea, fainting

Speculative: Blunted protective pain signalling in exercise; uterine and fetal effects in pregnancy; opioid downregulation

Monitoring

Marker	Target	Why
High-sensitivity C-reactive protein	< 1.0 mg/L	Body-wide inflammation; proxy for the anti-inflammatory signal
Interleukin-6	< 1.8 pg/mL	Most consistently reduced marker in the pooled analysis
Hemoglobin A1c	4.8–5.4%	High blood sugar impairs skin healing and nerve conduction
Vitamin B12	500–900 pg/mL	Deficiency mimics the pain treated, removes protective sensation
25-hydroxyvitamin D	40–60 ng/mL	Low levels linked to diffuse musculoskeletal pain; correctable
Red blood cell magnesium	5.0–6.5 mg/dL	Influences N-methyl-D-aspartate receptors and muscle cramping

Cadence: Response after the first session; skin after every use; pain, activity, and analgesic use at 2 and 4 weeks; tolerance at 6 to 8 weeks; therapy every 3 to 6 months; blood panel at 3 months, then 6 to 12 monthly.

Qualitative Assessment

Pain during the activity the therapy enables, rated 0 to 10
Pain at rest, rated 0 to 10, separate from movement-evoked pain
Weekly count of analgesic doses taken
Duration of carry-over relief after the current stops
Sleep onset latency and pain-related night wakings
Daily step count or weekly training volume
Global impression of change, rated at 4 weeks
Skin condition at electrode sites after each removal

Transcutaneous Electrical Nerve Stimulation for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment